Vimarsana
Biggest News Aggregation in the World

Mark Lowdell News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mark Lowdell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mark Lowdell Today - Breaking & Trending Today

INmune Bio, Inc. (NASDAQ:INMB) Q4 2023 Earnings Call Transcript - Vimarsana News

INmune Bio, Inc. (NASDAQ:INMB) Q4 2023 Earnings Call Transcript

INmune Bio, Inc. (NASDAQ:INMB) Q4 2023 Earnings Call Transcript March 28, 2024 INmune Bio, Inc. beats earnings expectations. Reported EPS is $-0.47, expectations were $-0.58. INMB isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Ladies and gentlemen, greetings and welcome […]

Source: yahoo.com
INmune Bio, Inc. (NASDAQ:INMB) Q3 2023 Earnings Call Transcript - Vimarsana News

INmune Bio, Inc. (NASDAQ:INMB) Q3 2023 Earnings Call Transcript

INmune Bio, Inc. (NASDAQ:INMB) Q3 2023 Earnings Call Transcript November 1, 2023 INmune Bio, Inc. beats earnings expectations. Reported EPS is $-0.00048, expectations were $-0.39. Operator: Greetings and welcome to the INmune Bio Third Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal […]

Source: yahoo.com
INmune Bio (NASDAQ:INMB) Coverage Initiated at Robert W. Baird - Vimarsana News

INmune Bio (NASDAQ:INMB) Coverage Initiated at Robert W. Baird

Analysts at Robert W. Baird initiated coverage on shares of INmune Bio (NASDAQ:INMB – Get Rating) in a note issued to investors on Wednesday, The Fly reports. The firm set an “outperform” rating on the stock. INmune Bio Stock Down 3.7 % Shares of INMB traded down $0.29 during mid-day trading on Wednesday, reaching $7.58. […]

INmune Bio (NASDAQ:INMB) Coverage Initiated at Robert W. Baird - Vimarsana News

INmune Bio (NASDAQ:INMB) Coverage Initiated at Robert W. Baird

Analysts at Robert W. Baird initiated coverage on shares of INmune Bio (NASDAQ:INMB – Get Rating) in a note issued to investors on Wednesday, The Fly reports. The firm set an “outperform” rating on the stock. INmune Bio Stock Down 3.7 % Shares of INMB traded down $0.29 during mid-day trading on Wednesday, reaching $7.58. […]

INmune Bio Inc.'s Chief Scientific Officer, Mark Lowdell, Ph.D. to Present Plenary Talk at International Society of Cell & Gene Therapy - Vimarsana News

INmune Bio Inc.'s Chief Scientific Officer, Mark Lowdell, Ph.D. to Present Plenary Talk at International Society of Cell & Gene Therapy

Presidential Plenary Lecture to be Presented Wednesday, May 31 at the ICST Opening Session BOCA RATON, Fla., May 24, 2023 --  INmune Bio Inc. announces that Mark Lowdell,... | June 11, 2023